Technology | May 15, 2013

ScottCare Launches Innovations in Management of Cardiac Implantable Device Data

Data management innovations provide device-neutral platforms to enhance clinical workflow and patient management

May 15, 2013 — ScottCare unveiled new advances for importing, monitoring and reviewing cardiac implantable electronic device (CIED) data at this year’s Heart Rhythm Society’s scientific session last week.

ScottCare’s OneView CRM 4.0 software release incorporates major workflow enhancements for importing, monitoring and reporting remote and in-clinic CIED data. The new functionality makes it easy for clinicians to select and import data from programmers, follow patients with alerts, create patient reports, and schedule patients for device interrogation.

The company also launched CRMConnect, a new software solution that will allow healthcare institutions to seamlessly import CIED data and reports into their electronic health record (EHR) systems. CRMConnect, a device-neutral interface, imports data from cardiac rhythm management (CRM) companies’ remote monitoring platforms and in-clinic programmers, and transfers it to customer’s EHR system in an automated fashion. With the software, hospitals and clinics will have the ability to streamline their EHR integration efforts and avoid the complexity and cost associated with setting up and managing multiple interfaces with their CRM suppliers.

In addition to data management technologies, Ambucor Health Solutions, a division of ScottCare, offers virtualized labor for 24/7/365 surveillance and remote interrogation for patients with cardiac implantable electronic devices. Ambucor optimizes CIED data and presents only meaningful information for patient care needs. This unique offering also facilitates scanning and reporting for Holter, event and Mobile Cardiac Telemetry diagnostic monitors.

“The management of continuous remote data emanating from wireless CIEDs delivered to multiple CRM vendor Web portals poses a vexing problem for physician and hospital practices,” said Colin Movsowitz, M.D., clinical cardiac electrophysiologist, Cardiology Consultants of Philadelphia. “This data needs to be assessed in a timely fashion and integrated into the electronic medical record. OneView and the Ambucor workforce provide a clinically robust and financially viable solution for the management of remote patient data.”

For more information: www.scottcare.com

 

Related Content

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia. 

News | Cardiac Diagnostics | October 06, 2020
October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc.
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry  #Amyloidosis

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the en
heart disease image
News | Cardiac Diagnostics | December 18, 2019
December 18, 2019 — In their latest report, “...
FDA Warns Troponin Tests Impacted by Biotin Dietary Supplement
Feature | Cardiac Diagnostics | November 05, 2019 | Dave Fornell, Editor
November 5, 2019 — The U.S.
Videos | Cardiac Diagnostics | October 29, 2019
Doctor Clyde Yancy was a keynote speaker and said doctors need to check their assumptions about patients at the door...
79-year-old Tony Marovic had a right carotid endarterectomy shortly after discovering a 95 percent blockage of his carotid artery at a health and wellness screening event

79-year-old Tony Marovic had a right carotid endarterectomy shortly after discovering a 95 percent blockage of his carotid artery at a health and wellness screening event. Image courtesy of University Hospitals.

News | Cardiac Diagnostics | October 16, 2019
Health and wellness screenings are more than just nice events for the community – they can save lives. A Mentor, Ohio,...
Pesticide Exposure May Increase Heart Disease and Stroke Risk

Image courtesy of zefe wu from Pixabay

News | Cardiac Diagnostics | October 15, 2019
On-the-job exposure to high levels of pesticides raised the risk of heart disease and stroke in a generally healthy...
World Heart Federation Launches Global Roadmap on Cardiovascular Disease Prevention Among Diabetics
News | Cardiac Diagnostics | September 04, 2019
At the European Society of Cardiology (ESC) Congress 2019 together with the World Congress of Cardiology, the World...